scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...731738M |
P356 | DOI | 10.1371/JOURNAL.PONE.0031738 |
P932 | PMC publication ID | 3281005 |
P698 | PubMed publication ID | 22359625 |
P5875 | ResearchGate publication ID | 221856118 |
P50 | author | Cecília Rodrigues | Q30421070 |
Helena Cortez-Pinto | Q43042720 | ||
Rui E. Castro | Q43087499 | ||
P2093 | author name string | Teresinha Evangelista | |
João Coutinho | |||
Mariana Verdelho Machado | |||
Adília Costa | |||
Duarte M S Ferreira | |||
Fátima Carepa | |||
Ana Rita Silvestre | |||
P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes | Q29616567 | ||
Long-term follow-up of patients with NAFLD and elevated liver enzymes | Q29620024 | ||
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis | Q30448524 | ||
Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults | Q33592857 | ||
Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans | Q33755056 | ||
Pathogenesis of insulin resistance in skeletal muscle | Q33812448 | ||
Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans | Q34099337 | ||
Lipid-induced insulin resistance: unravelling the mechanism | Q34370958 | ||
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice | Q35108391 | ||
Follow-up report on the diagnosis of diabetes mellitus | Q35567871 | ||
Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. | Q35785726 | ||
High-fat diets cause insulin resistance despite an increase in muscle mitochondria | Q36693972 | ||
Muscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction | Q36693993 | ||
Lipid mediators of insulin resistance | Q36867145 | ||
Lipid accumulation in non-adipose tissue and lipotoxicity | Q37068180 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle | Q37175187 | ||
Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. | Q37246341 | ||
PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions | Q37299286 | ||
Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals | Q37341267 | ||
The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease | Q37736540 | ||
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | Q37805851 | ||
Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. | Q37845219 | ||
Intramuscular lipid content is increased in obesity and decreased by weight loss | Q39535127 | ||
Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. | Q40818302 | ||
Ceramide content is increased in skeletal muscle from obese insulin-resistant humans | Q42454790 | ||
Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats. | Q51480723 | ||
Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. | Q51554321 | ||
Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. | Q51605806 | ||
Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. | Q54599587 | ||
Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle | Q54986901 | ||
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis | Q57760188 | ||
A position statement on NAFLD/NASH based on the EASL 2009 special conference | Q61338101 | ||
Skeletal Muscle Lipogenic Protein Expression Is Not Different between Lean and Obese Individuals: A Potential Factor in Ceramide Accumulation | Q63805149 | ||
Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement | Q67735595 | ||
Lipid oxidation is reduced in obese human skeletal muscle | Q73127280 | ||
Mitochondrial function: use it or lose it | Q79721968 | ||
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality | Q83500394 | ||
Lifelong physical activity modulation of the skeletal muscle mitochondrial proteome in mice. | Q43049782 | ||
Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. | Q43251946 | ||
Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity | Q43935425 | ||
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation | Q44095719 | ||
Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats | Q44262550 | ||
Skeletal muscle lipid metabolism with obesity | Q44355154 | ||
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity | Q44392926 | ||
Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. | Q44772657 | ||
Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice | Q46232844 | ||
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity | Q46410788 | ||
Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. | Q47328770 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
insulin resistance | Q1053470 | ||
morbid obesity | Q9051491 | ||
P304 | page(s) | e31738 | |
P577 | publication date | 2012-02-16 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance | |
P478 | volume | 7 |
Q58582579 | ATP Production of Muscle Mitochondria after Acute Exercise in Lean and Obese Humans |
Q60922887 | Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? |
Q36687279 | Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adults |
Q33844787 | Developmental origins of nonalcoholic fatty liver disease |
Q37629154 | Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. |
Q56967616 | Ectopic lipid storage in non-alcoholic fatty liver disease is not mediated by impaired mitochondrial oxidative capacity in skeletal muscle |
Q61452212 | Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD |
Q51835057 | Metabolic adaptations to HFHS overfeeding: how whole body and tissues postprandial metabolic flexibility adapt in Yucatan mini-pigs. |
Q38113765 | Mitochondria: sensors and mediators of innate immune receptor signaling. |
Q37670352 | Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles |
Q50238978 | Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet. |
Q37002532 | Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease |
Q64052598 | Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study |
Q24563068 | Non-alcoholic fatty liver disease: what the clinician needs to know |
Q91727581 | Obesity modifies the stoichiometry of mitochondrial proteins in a way that is distinct to the subcellular localization of the mitochondria in skeletal muscle |
Q47745065 | Plasma Amino Acids Stimulate Uncoupled Respiration of Muscle Subsarcolemmal Mitochondria in Lean but Not Obese Humans |
Q38202220 | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. |
Q39144663 | The biochemical alterations underlying post-burn hypermetabolism |
Search more.